A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Toddlers 12 to 15 Months of Age Receiving a Single Booster Dose

NCT07406334 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Pneumonia, Bacterial

Interventions

BIOLOGICAL: Pn-MAPS30plus
COMBINATION_PRODUCT: PCV20

Sponsor

GlaxoSmithKline